Fethi Emre Ustabaşıoğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fethi Emre Ustabaşıoğlu has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Cesur Samanci
Department of Radiology, Sultan Abdulhamid Han Training and Research Hospital, Haydarpasa, Istanbul, Turkey
6 shared publications - Mert Çiftdemir
Department of Orthopaedics and Traumatology, Trakya University School of Medicine, Edirne, Türkiye
6 shared publications - Burak Günay
Department of Radiology, Trakya University Faculty of Medicine, Turkey
5 shared publications - Ufuk Usta
Trakya University Medical School
5 shared publications - Cihan Öztürk
Department of Cardiology, Trakya University Faculty of Medicine, Edirne, Türkiye
3 shared publications - Deniz Alis
Acibadem Mehmet Ali Aydinlar University, School of Medicine, Department of Radiology, Istanbul, Turkey
3 shared publications
Latest Publications
- 20 September 2026
- Published by Springer Nature in Journal of Ultrasound
- Vol. 29 (4) , 855-863
Combined ultrasonographic and clinical assessment of bioimpedance-defined volume status in dialysis patients: a diagnostic accuracy study
- 20 September 2026
- Published by Springer Nature in Journal of Ultrasound
- Vol. 29 (4) , 855-863
Combined ultrasonographic and clinical assessment of bioimpedance-defined volume status in dialysis patients: a diagnostic accuracy study
- 28 February 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (6) , 1393-1395
Pathologic fracture following neoadjuvant therapy: a paradoxical radiological sign of effective treatment response
- 28 February 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (6) , 1393-1395
Pathologic fracture following neoadjuvant therapy: a paradoxical radiological sign of effective treatment response
- 17 February 2026
- Published by Academician Publishing
- p. 229-234
Gri Literatür
Bu bölüm, geleneksel ticari yayıncılık kanallarının dışında kalan ve "gri literatür" olarak adlandırılan kaynakların akademik araştırmadaki kritik rolünü ele almaktadır. Gri literatür; tezler, konferans bildirileri, teknik raporlar, ön baskılar (preprints) ve klinik araştırma kayıtları gibi çeşitli formatları kapsar. Bu kaynakların stratejik önemi üç ana başlık altında incelenmektedir: araştırmalara güncellik kazandırması, yayın yanlılığını (publication bias) önlemesi ve veritabanı aramalarında gözden kaçan çalışmaları tespit ederek çift kontrol sağlaması. Özellikle negatif veya nötr sonuçlu çalışmaların yayınlanmama eğilimi göz önüne alındığında, gri literatür taraması, kanıt sentezinin daha dengeli ve kapsamlı olmasını sağlar. Bu bölüm, genç akademisyenlerin yüksek kaliteli gri literatürü etkin bir şekilde belirlemeleri, değerlendirmeleri ve dahil etmeleri için pratik bir rehber sunarak araştırmalarının kapsamını ve geçerliliğini artırmayı hedefler. This chapter addresses the critical role of "grey literature"—resources produced outside of traditional commercial publishing channels—in academic research. Grey literature encompasses various formats, including theses, conference proceedings, preprints, and clinical trial registries. Its strategic importance is examined through three key benefits: providing currency to research, preventing publication bias, and acting as a cross-check to identify published studies missed by database searches. Given the tendency for studies with negative or neutral results to remain unpublished, searching grey literature is crucial for creating a more balanced and comprehensive evidence synthesis. This chapter provides a practical guide for young academics to effectively identify, evaluate, and incorporate high-quality grey literature, enhancing their research's comprehensiveness and validity.
- 17 February 2026
- Published by Academician Publishing
- p. 229-234
Gri Literatür
Bu bölüm, geleneksel ticari yayıncılık kanallarının dışında kalan ve "gri literatür" olarak adlandırılan kaynakların akademik araştırmadaki kritik rolünü ele almaktadır. Gri literatür; tezler, konferans bildirileri, teknik raporlar, ön baskılar (preprints) ve klinik araştırma kayıtları gibi çeşitli formatları kapsar. Bu kaynakların stratejik önemi üç ana başlık altında incelenmektedir: araştırmalara güncellik kazandırması, yayın yanlılığını (publication bias) önlemesi ve veritabanı aramalarında gözden kaçan çalışmaları tespit ederek çift kontrol sağlaması. Özellikle negatif veya nötr sonuçlu çalışmaların yayınlanmama eğilimi göz önüne alındığında, gri literatür taraması, kanıt sentezinin daha dengeli ve kapsamlı olmasını sağlar. Bu bölüm, genç akademisyenlerin yüksek kaliteli gri literatürü etkin bir şekilde belirlemeleri, değerlendirmeleri ve dahil etmeleri için pratik bir rehber sunarak araştırmalarının kapsamını ve geçerliliğini artırmayı hedefler. This chapter addresses the critical role of "grey literature"—resources produced outside of traditional commercial publishing channels—in academic research. Grey literature encompasses various formats, including theses, conference proceedings, preprints, and clinical trial registries. Its strategic importance is examined through three key benefits: providing currency to research, preventing publication bias, and acting as a cross-check to identify published studies missed by database searches. Given the tendency for studies with negative or neutral results to remain unpublished, searching grey literature is crucial for creating a more balanced and comprehensive evidence synthesis. This chapter provides a practical guide for young academics to effectively identify, evaluate, and incorporate high-quality grey literature, enhancing their research's comprehensiveness and validity.
- Open Access
- 31 December 2025
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 59 (6) , 485-492
Retrospective clinicopathological analysis of 193 cases of bone and soft tissue tumors in the foot and ankle
Objective: The aim of this study was to evaluate the epidemiological features, anatomical distribution, and treatment methods of bone and soft tissue tumors in the foot and ankle region. Methods: This retrospective study included 193 cases evaluated at the musculoskeletal tumor board of the institution between January 2014 and December 2024. Patients’ demographic data (84 males, 109 females; mean age, 37.8 years), lesion type, anatomical location, his topathological subtype, and treatment modalities were recorded. Tumors were classified according to the 2020 World Health Organization classification of bone and soft tissue tumors. Results: Of the 193 cases, 128 (66.3%) were true tumors and 65 (33.7%) were tumor-like lesions. Among the tumors, 70 (54.7%) were bone tumors, 54 (42.2%) were soft tissue tumors, and 4 (3.1%) were metastases. Benign lesions accounted for 79.7%, malignant for 14.0%, and intermediate for 6.3% of all tumors. Tumors were most frequently located in the forefoot (44%), followed by the ankle (29%). Intraosseous lipoma was the most common benign bone tumor, giant cell tumor of the tendon sheath the most common benign soft tissue tumor, and ganglion cyst the most frequent tumor-like lesion. Excisional biopsy was the main treatment, whereas amputation was mainly performed for malignant tumors. Conclusion: Foot and ankle tumors are rare but clinically significant as misdiagnosis or delayed diagnosis can lead to poor outcomes. Although most are benign, malignant cases, especially in the ankle region, require aggressive management. Awareness of their regional distribution and histopathological spectrum is essential for early recognition, accurate diagnosis, and appropriate treatment planning. Cite this article as: Yıldırım S, Çiftdemir M, Salih O, Ustabaşıoğlu FE, Üstün F, Usta U. Retrospective clinicopathological analysis of 193 cases of bone and soft tissue tumors in the foot and ankle. Acta Orthop Traumatol Turc., 2025;59(6):485-492.
- 31 December 2025
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 59 (6) , 485-492
Open AccessRetrospective clinicopathological analysis of 193 cases of bone and soft tissue tumors in the foot and ankle
Objective: The aim of this study was to evaluate the epidemiological features, anatomical distribution, and treatment methods of bone and soft tissue tumors in the foot and ankle region. Methods: This retrospective study included 193 cases evaluated at the musculoskeletal tumor board of the institution between January 2014 and December 2024. Patients’ demographic data (84 males, 109 females; mean age, 37.8 years), lesion type, anatomical location, his topathological subtype, and treatment modalities were recorded. Tumors were classified according to the 2020 World Health Organization classification of bone and soft tissue tumors. Results: Of the 193 cases, 128 (66.3%) were true tumors and 65 (33.7%) were tumor-like lesions. Among the tumors, 70 (54.7%) were bone tumors, 54 (42.2%) were soft tissue tumors, and 4 (3.1%) were metastases. Benign lesions accounted for 79.7%, malignant for 14.0%, and intermediate for 6.3% of all tumors. Tumors were most frequently located in the forefoot (44%), followed by the ankle (29%). Intraosseous lipoma was the most common benign bone tumor, giant cell tumor of the tendon sheath the most common benign soft tissue tumor, and ganglion cyst the most frequent tumor-like lesion. Excisional biopsy was the main treatment, whereas amputation was mainly performed for malignant tumors. Conclusion: Foot and ankle tumors are rare but clinically significant as misdiagnosis or delayed diagnosis can lead to poor outcomes. Although most are benign, malignant cases, especially in the ankle region, require aggressive management. Awareness of their regional distribution and histopathological spectrum is essential for early recognition, accurate diagnosis, and appropriate treatment planning. Cite this article as: Yıldırım S, Çiftdemir M, Salih O, Ustabaşıoğlu FE, Üstün F, Usta U. Retrospective clinicopathological analysis of 193 cases of bone and soft tissue tumors in the foot and ankle. Acta Orthop Traumatol Turc., 2025;59(6):485-492.
- 4 October 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105629
Evaluation of detorsioned testes after torsion using advanced functional ultrasonography
- 4 October 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105629
Evaluation of detorsioned testes after torsion using advanced functional ultrasonography
- Open Access
- 28 May 2025
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 59 (3) , 179-184
Giant-cell rich osteosarcoma: A report of 3 cases depicting a diagnostic challenge requiring serious attention
Giant cell-rich osteosarcoma (GCRO) is a rare variant of osteosarcoma with unusual radiological and histopathological features that make its diagnosis challenging. The most critical and unusual feature of GCRO is that it has a purely osteolytic appearance. Therefore, GCRO cases are frequently subject to delayed diagnosis or incorrect treatment owing to misdiagnosis. This negatively affects the prognosis of these patients. In this study, 3 young adult cases are presented. The first case describes a young female patient who underwent repeated curettages due to a misdiagnosis of a giant-cell bone tumor, and the second case describes a delay in diagnosis in a young male patient who was misdiagnosed with an aneurysmal bone cyst. The final case report describes a young woman who was diagnosed early, treated promptly, and had a good prognosis. One of the poor prognosis cases in this report was treated with amputation, and the other was alive with multiple metastases. Misdiagnosis or delayed diagnosis leads to a poor prognosis in such cases. To make a diagnosis, it is necessary to have knowledge and to be suspicious of the radiological features of this rare variant. Giant cell-rich osteosarcoma should be among the differential diagnosis options when dealing with pure metaphysiodiaphyseal osteolytic bone lesions in young adults. To avoid misdiagnosis or delay, it is necessary to have knowledge and to be suspicious of this rare variant. Cite this article as: Çiftdemir M, Ünyilmaz C, Ustabaşioğlu FE, Usta U. Giant-cell rich osteosarcoma: A report of three cases depicting a diagnostic challenge requiring serious attention. Acta Orthop Traumatol Turc., 2025;59(3):179-184.
- 28 May 2025
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 59 (3) , 179-184
Open AccessGiant-cell rich osteosarcoma: A report of 3 cases depicting a diagnostic challenge requiring serious attention
Giant cell-rich osteosarcoma (GCRO) is a rare variant of osteosarcoma with unusual radiological and histopathological features that make its diagnosis challenging. The most critical and unusual feature of GCRO is that it has a purely osteolytic appearance. Therefore, GCRO cases are frequently subject to delayed diagnosis or incorrect treatment owing to misdiagnosis. This negatively affects the prognosis of these patients. In this study, 3 young adult cases are presented. The first case describes a young female patient who underwent repeated curettages due to a misdiagnosis of a giant-cell bone tumor, and the second case describes a delay in diagnosis in a young male patient who was misdiagnosed with an aneurysmal bone cyst. The final case report describes a young woman who was diagnosed early, treated promptly, and had a good prognosis. One of the poor prognosis cases in this report was treated with amputation, and the other was alive with multiple metastases. Misdiagnosis or delayed diagnosis leads to a poor prognosis in such cases. To make a diagnosis, it is necessary to have knowledge and to be suspicious of the radiological features of this rare variant. Giant cell-rich osteosarcoma should be among the differential diagnosis options when dealing with pure metaphysiodiaphyseal osteolytic bone lesions in young adults. To avoid misdiagnosis or delay, it is necessary to have knowledge and to be suspicious of this rare variant. Cite this article as: Çiftdemir M, Ünyilmaz C, Ustabaşioğlu FE, Usta U. Giant-cell rich osteosarcoma: A report of three cases depicting a diagnostic challenge requiring serious attention. Acta Orthop Traumatol Turc., 2025;59(3):179-184.
- Open Access
- 8 January 2025
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 42 (3) , 274-275
Is MINOCA Syndrome Causing Fatal Left Ventricular Aneurysms Less Innocent than It Appears?
- 8 January 2025
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 42 (3) , 274-275
Open AccessIs MINOCA Syndrome Causing Fatal Left Ventricular Aneurysms Less Innocent than It Appears?
- Open Access
- 26 November 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 42 (1) , 83-85
FAVA Syndrome with Unique Synovial Localisation Mimicking Diffuse Pigmented Villonodular Synovitis
- 26 November 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 42 (1) , 83-85
Open AccessFAVA Syndrome with Unique Synovial Localisation Mimicking Diffuse Pigmented Villonodular Synovitis
- Open Access
- 20 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (14) , 1574
Comparison of the Efficacy of Percutaneous Microwave Ablation Therapy versus Laparoscopic Partial Nephrectomy for Early-Stage Renal Tumors
This study aimed to compare the efficacy of percutaneous microwave ablation therapy (MWAT) and laparoscopic partial nephrectomy (LPN) in early-stage renal cell carcinoma (RCC) classified as T1a; a retrospective analysis was conducted on patients treated between January 2017 and November 2023. Oncological outcomes, radiological recurrence, length of stay (LOS), and costs were evaluated. The study included 110 patients, with no significant differences between the two groups regarding residual tumors, local tumor progression, and disease-free survival rates (p > 0.05). The LPN group showed significantly lower pre/postoperative serum urea and creatinine and higher estimated glomerular filtration rate values, whereas the MWA group experienced significantly lower mean costs, complication rates, LOS in the hospital, and procedure durations (p ≤ 0.05). However, post-procedure residual tumors and local tumor progression rates did not differ significantly between the LPN and MWAT groups (p > 0.05). MWAT is as effective as LPN for T1a RCC lesions. In addition, MWAT has lower costs than LPN and is a cost-effective treatment method. Therefore, MWAT minimizes hospital stay and complications and since the oncological results are similar to LPN, it might be considered as the first choice of treatment in young patients.
- 20 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (14) , 1574
Open AccessComparison of the Efficacy of Percutaneous Microwave Ablation Therapy versus Laparoscopic Partial Nephrectomy for Early-Stage Renal Tumors
This study aimed to compare the efficacy of percutaneous microwave ablation therapy (MWAT) and laparoscopic partial nephrectomy (LPN) in early-stage renal cell carcinoma (RCC) classified as T1a; a retrospective analysis was conducted on patients treated between January 2017 and November 2023. Oncological outcomes, radiological recurrence, length of stay (LOS), and costs were evaluated. The study included 110 patients, with no significant differences between the two groups regarding residual tumors, local tumor progression, and disease-free survival rates (p > 0.05). The LPN group showed significantly lower pre/postoperative serum urea and creatinine and higher estimated glomerular filtration rate values, whereas the MWA group experienced significantly lower mean costs, complication rates, LOS in the hospital, and procedure durations (p ≤ 0.05). However, post-procedure residual tumors and local tumor progression rates did not differ significantly between the LPN and MWAT groups (p > 0.05). MWAT is as effective as LPN for T1a RCC lesions. In addition, MWAT has lower costs than LPN and is a cost-effective treatment method. Therefore, MWAT minimizes hospital stay and complications and since the oncological results are similar to LPN, it might be considered as the first choice of treatment in young patients.
- 11 March 2024
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 36 (7)
Apical Thrombus Mimicking Ventricular Septal Rupture
A 51-year-old man with chest pain was admitted to the emergency department. The patient was taken to the coronary angiography lab with a diagnosis of inferior myocardial infarction. Clinical Images from Journal of Invasive Cardiology. apical thrombus ventricular septal rupture Anticoagulation Acute Myocardial Infarction
- 11 March 2024
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 36 (7)
Apical Thrombus Mimicking Ventricular Septal Rupture
A 51-year-old man with chest pain was admitted to the emergency department. The patient was taken to the coronary angiography lab with a diagnosis of inferior myocardial infarction. Clinical Images from Journal of Invasive Cardiology. apical thrombus ventricular septal rupture Anticoagulation Acute Myocardial Infarction